News

CORPORATE NEWSROOM & PERSPECTIVES ——

Strategic Updates &
Executive Perspectives

Official corporate announcements, regulatory filings, clinical partnership expansions, and technical white papers from Bodylia Life Sciences LLP headquartered in Ahmedabad, India.

📍 Ahmedabad, Gujarat 🏛 MCA Incorporated LLP 📑 Audited Regulatory Filings
Corporate & Governance 13 October 2026 ⏱ 3 min read 📍 Ahmedabad, India
Dr. Ayyappan Thangavel, Medical Advisor, Bodylia Life Sciences LLP
Dr. Ayyappan Thangavel

Bodylia Life Sciences Appoints Distinguished Surgeon Dr. Ayyappan Thangavel to Advisory Board

Plastic, aesthetic, and reconstructive surgeon with over 35 years of global surgical leadership across Johns Hopkins Aramco Healthcare, Prince of Wales Hospital Hong Kong, and Apollo Hospitals joins Bodylia Life Sciences LLP as Medical Advisor (Aesthetic Surgery & Regenerative Medicine).

Executive Briefing Highlights
35+ Years Global Surgical Leadership
Career spanning Johns Hopkins Aramco Healthcare, Prince of Wales Hospital (CUHK), Apollo Hospitals Intl, and Leelavati Hospitals Gift City.
Regenerative Medicine & Positioning
Guides clinical strategy, cellular regeneration co-factors, and medical positioning in women's wellness formulations.
Statutory & Governance Filing
Announcement Date
13 October 2026
Board Role
Advisory Board Member
Designation
Medical Advisor
Clinical Experience
35+ Years
Key Institutions
Johns Hopkins, CUHK
OFFICIAL ARCHIVE ——

All Announcements & Disclosures

Krunal Shah, Advisory Board Member (Brand & Growth Advisor)
Krunal Shah
Brand & Growth Advisor • Founder of Yegital
Corporate & Governance 6 October 2026 ⏱ 3 min read

Bodylia Life Sciences Appoints Growth Operator and Search Strategist Krunal Shah to Advisory Board

Founder of Yegital joins Bodylia's Advisory Board, bringing technical search engine architecture, contribution-margin attribution, and algorithmic resilience.

Key Impact: Over INR 50 Cr+ attributable revenue delivered across 2,500+ projects; structuring durable discoverability for Bodylia's WHO-GMP formulations.
Parminder Kaur, Strategic Board Advisor - Regulatory Affairs
Parminder Kaur
Strategic Advisor - Regulatory Affairs • RegPak & Ashcure
Corporate & Governance 29 September 2026 ⏱ 3 min read

Bodylia Life Sciences Appoints Global Regulatory Expert Parminder Kaur to Advisory Board

Founder of RegPak BioPharma Consulting and Ashcure Pharma B.V. joins Bodylia, bringing decades of European Commission, EMA, and cross-border nutraceutical compliance.

Regulatory Scope: Led Innovative Medicines Initiative at the European Commission; guiding Bodylia's global market authorization and EU approval pathways.
Syed Nadeem Jafri, Independent Global Distribution Director
Syed Nadeem Jafri
Independent Global Distribution Director • Hearty Mart
Corporate & Governance 21 September 2026 ⏱ 3 min read

Social Entrepreneur Syed Nadeem Jafri Appointed to Advisory Board as Independent Global Distribution Director

Founder and Chief Mentor of Hearty Mart joins Bodylia's Advisory Board, bringing over two decades of entrepreneurial excellence in omnichannel supply chains and scalable retail.

Distribution Mandate: Microenterprise franchise model studied at IIM Ahmedabad and MICA; expanding Bodylia's multi-channel access across India and overseas.
Ministry of Corporate Affairs (MCA)
Statutory Filing • Limited Liability Partnership Act 2008
Corporate & Governance 29 March 2026 ⏱ 4 min read

Bodylia Life Sciences LLP Formally Incorporated in India: Accelerating Cross-Border Wellness Alliances

Strategic milestone establishes dedicated Indian operating entity in Ahmedabad to streamline CDSCO and FSSAI regulatory pathways and WHO-GMP manufacturing partnerships.

Statutory Milestones: Conforms 100% to FSSAI Schedule IV nutraceutical regulations; cements direct alliances with premier WHO-GMP manufacturing facilities.
Technical White Paper
ICH Q7 & WHO TRS 986 Annex 2 Standards
Regulatory & Supply Chain 15 February 2026 ⏱ 5 min read

Technical White Paper: WHO-GMP Compliance Benchmarks and Quality Validation in Cross-Border Supply Chains

Executive briefing on audit readiness, ICP-MS heavy metal validation (AOAC 2013.06), and stability testing standards under ICH Climatic Zone IVb conditions.

White Paper PDF (1.8 MB)
Quality Specs: Climatic Zone IVb testing (30°C / 75% RH) ensuring 36-month stability retention and Common Technical Document (CTD) filing readiness.
Clinical Nutrition Monograph
ICMR-NIN 2020 DRI Calibration Baseline
Formulations & Science 10 January 2026 ⏱ 4 min read

Strategic Assessment: ICMR Micronutrient Reference Standards and Evidence-Based Clinical Nutrition

Scientific review on calibrating therapeutic wellness formulations directly to the ICMR-NIN 2020 Dietary Reference Intakes for Indian adults and women.

Clinical Monograph PDF (1.4 MB)
Biochemical Focus: Overcomes high cereal phytate binding by utilizing chelated liposomal iron and Quatrefolic® active L-methylfolate.